4 Patents
- US126124632026Mesothelin-targeted CD40 Agonistic Multispecific Antibody Constructs for the Treatment of Solid Tumors
Amgen Inc.
0 cites - 0 cites
- 0 cites
- US119266722024Mesothelin-targeted CD40 Agonistic Multispecific Antibody Constructs for the Treatment of Solid Tumors
Amgen Inc.
0 cites